Safran set to open $76mn 3D printing facility in Bordeaux

By Sean Galea-Pace
The leading France-based aerospace company, Safran Group, has confirmed it will unveil a $76mn additive manufacturing facility in Bordeaux, according to...

The leading France-based aerospace company, Safran Group, has confirmed it will unveil a $76mn additive manufacturing facility in Bordeaux, according to 3D Printing Industry.

The company has received local support for the complex that is anticipated to create approximately 200 jobs in engineering, production and research and development.

Born out of a merger between Snecma and Sagem, the Safran Group operates three main divisions; aerospace propulsion, aircraft equipment and defence.

SEE ALSO:

Alain Rousset, President of the region that also proposed a “Plan for Digital Aquitaine,” commented: “Safran’s choice shows the attractiveness of our territory and the quality of the ecosystem we have built around the technologies of the future. Additive manufacturing is crucial for our metallurgy sector.”

During the past ten years, Safran has teamed up with Airbus to 3D print a titanium hydraulic part for the A350, with the firm applying 3D printing technology for the past ten years.

Share

Featured Articles

COP28: GMIS unites manufacturing sector for decarbonisation

The Global Manufacturing & Industrialisation Summit joins COP28, in what Managing Director, Namir Hourani, hopes will create ‘a sustainable future’

Panel round-up for Manufacturing Digital LIVE

At Manufacturing Digital LIVE, experts will share their exclusive insights at two panels, covering leadership in manufacturing and sustainability

Driving sustainable fashion supply chains with TrusTrace

New Look has partnered with TrusTrace to reduce its carbon footprint & track emissions. TrusTrace CEO Shameek Ghosh tells us about supply chain visibility

The impact of 5G technology in the manufacturing industry

Technology

Manufacturing Digital LIVE: Tech, sustainability & more

Smart Manufacturing

COP28 to discuss emission reduction in pharma manufacturing

Sustainability & ESG